News

Sucampo Pharma and Takeda are expecting to recruit around 420 patients in 140 sites in US and Europe. In the trial, the patients will be randomized to receive

The facility, which is expected to be operational in the fourth quarter of next financial year, will have facilities such as process chemistry labs, oncology chemical labs, formulation

Following the batch failures, the company released a statement indicating the problems are within normal industry failure rates experienced for the commencement of biologic commercial manufacturing. The offending

The acquisition in Serbia strengthens Azelis’ position in the region, as Finkochem is the second largest distributor in the country. Azelis will now be able to accelerate growth

The iSelect custom genotyping products allow researchers to draw on the latest advances from genome-wide association studies, next-generation whole-genome sequencing, and exome sequencing studies for variant confirmation, fine

The Nicorette product is being manufactured and packaged by Cambrex Zenara in its Hyderabad, India facility. Cambrex president and CEO Steven Klosk said that Nicotine Replacement Therapeutics represent

According to the agreement, Seattle Genetics is expected to receive an upfront of $8m from Pfizer. Under the agreement, Pfizer has the responsibility for manufacturing, research and commercialization

As per the agreement, Lupin is expected to supply the tuberculosis drug to Farmanguinhos for next 5 years and will support the company in establishing a local manufacturing

Sumavel DosePro offers fast-acting, easy-to-use, needle-free subcutaneous administration of sumatriptan as a potential treatment alternative to oral and nasal triptans, and simple, convenient administration when compared to traditional,